Tartışma: Uyku apnesi yakınması olan hastalarda seksüel performansta da gerileme olabileceği ve apne tedavisi ile performansta belirgin bir düzelme olduğu saptanmıştır.
Introduction
Obstructive sleep apnea (OSA) is the most prevalent sleep disorder affecting 2.2-4.8% of men [1] . It is characterized by periods of functional obstruction of the upper airway during sleep, resulting in decreases in arterial oxygen saturation and transient arousals. The major symptoms associated with OSA are excessive daytime sleepiness and loud snoring, fatigue, gasping, nocturia, nocturnal sweating, morning headaches, heartburn and erectile dysfunction [2] [3] [4] [5] [6] [7] . In this study our starting point was to point out whether if the sexual performance of sleep apne patients is affected or not. The second point was to show whether if the sexual performance improved after the sleep apnea therapy.
Material and Method
All patients were signed consent forms in order to participate in the study. Polysomnographic study was performed during two consecutive nights and CPAP titrations were done another day. At least 7 hours of sleep was recorded. Patients were also performed electroencephalography (EEG), electroculography (EOG), electromiyography (EMG) and electrocardiography (ECG). Inhalation of the patients was followed up with a nasal cannula. Polysomnography results were evaluated according to the classification criterias of the American Sleep Academy. Respiratory arrest for at least 10 seconds or more was defined as apnea, while reduction of the 50% of breathing for at least 10 seconds was defined as hypopnea. Total of apnea and hypopnea episodes in one hour was considered as apnea-hypopnea index (AHI 
Statistical analysis
Statistical evaluation was applied on Windows SPSS-11.5. When scatter of data was examined on SPSS program, normality of data was controlled with tests and graphical scatter. As the scatter of data was not normal, Wilcoxon signed ranks, Kruskal Wallis tests and non-parametric tests were applied. Wilcoxon signed ranks, Kruskal Wallis tests and non-parametic statistics were used to evaluate differences in IIEF scores before and after the treatment. p<0.001 was considered as significant.
Results
Our study was initiated with a total of 141 patients. Figure 2 ). Treatment modalities; determined by ENT inspection findings and disease severity; were shown in Figure1
Discussion
Obstructive sleep apnea syndrome is an important disease which develops due to reoccurring disorders (apnea, hypopnea) as a result of blocked upper air route during sleep [10] . Studies showed that there is a relationship between OSAS and sexual dysfunction [7] . In fact, sleep and erectile function, even in relation to each other very closely, are two intertwined functions. Nocturnal erection, which is important in erection patophysiology, prominently encompasses the REM phase of the sleep. Sleep-related nocturnal erections, called as Nocturnal Penile Tumescence (NPT), mainly occur in REM sleep [11] . Presence of high sympathetic activity in patients with OSAS, especially at night, could prevent the physiological mechanisms of normal erection [12] . Penile growth by filling of blood and increase in partial oxygen pressure occurs during the NPT. Therefore, NPT is believed to be an internal mechanism to protect morphological feature of corpora cavernous [13] . Men have 3-5 episodes of NPT per night, which take approximately 30-60 minutes [14] . On the other hand, some of the previous studies demonstrated that nocturnal LH and testosterone levels in patients with OSAS were significantly lower than the control group. The relationship between ED and pituitary-gonadal axis in sleep disorders was evaluated and showed that OSAS affects sexual performance and causes problems [15] .Low plasma levels of nitric oxide (NO), an important vasodilator which plays role in the physiology of erection, is responsible for ED in patients with OSAS, as well as vascular diseases [16] . Additionally, it was shown that hypoxia increased the level of endothelin, a potent vasoconstrictor, in patients with OSAS [17] . Possible mechanisms explaining the relationship between erectile dysfunction and sleep disorder were summarized as follows: depending on exchange in the pituitary-gonadal axis leading to a decrease in LH, testosterone levels and increase in sympathetic activity, rising norepinephrine levels and peripheral nerve dysfunction, in association with nocturnal hypoxia, suppression of no production by oxidative stress, in response to acetylcholine and increased production of endothelin, leading to vasoconstriction and antagonizing penile tumescence [18] . OSAS can be defined according to apnea-hypopnea index. Apnea-Hypopnea Index is a parameter used in diagnosing OSAS which also indicates the severity of the disease as light AHI 5-14, mild AHI 15-30, strong AHI>30 [8] . In our study we have observed that there was a significant sexual performance increase for the patients coming in early phase 3rd month controls who, according to AHI have been diagnosed OSAS and who have received ASAS treatment (Surgery (UPF), RF of the soft palate or CPAP). However, no significant difference in terms of superiority of treatment options to each other may probably be due to lower number of patients in RF group. We hope that the number of patients in treatment groups will be sufficient for the evaluation of late-term results. CPAP therapy and nocturnal hypoxemia (the lowest oxygen saturation measured at night) was determined the most significant variable with ED. Efficacy of CPAP may be occurring via increasing circulating levels of NO [19] . CPAP therapy also reduced the level endothelin by reducing hypoxia [4] . Significant improvements in erectile function with CPAP therapy in OSAS patients was first reported by Karacan and Karatas in 1995 [20] .
On the other hand, in recent studies, significant improvements in erectile function with CPAP therapy have been reported significant post-treatment improvements in the lowest oxygen saturation and IIEF scores [21, 22] . In our study, the majority of patients underwent CPAP therapy and then IIEF scores before and after treatment were compared and statistically significant difference was determined. In recent years, safety and efficacy of sildenafil treatment in erectile dysfunction of OSAS patients have been reported in studies [23, 24] . The addition of parenteral testosterone therapy in patients with OSAS and hypogonadism have been reported more beneficial in improvement of erectile function [25] .
In this pilot study, we observed that patients with OSAS and high AHI often had moderate and high IIEF symptom scores. We also detected that even only treating OSAS with no need for any additional medical treatment may lead to a satisfactory sexual performance improvement. In our study, changes in IIEF scores in patients with OSAS before and after treatment and the relationship between age, body mass index, severity of disease (AHI) and treatment modalities was not statistically significant. Although minimum and maximum values of IIEF score before treatment were higher than after treatment values , median value was higher after treatment and this elevation was statistically significant. It was detected that sexual performance can also be deteriorated and significant improvement in performance can be provided by the treatment of apnea in patients with sleep apnea in this study. We suggest that treatment of OSAS should be considered besides medical treatment for the improvement of sexual function in patients with OSAS with erectile dysfunction.
